Cargando…
Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
INTRODUCTION: Soluble urokinase plasminogen activator receptor (suPAR) level reflects the general condition of the organism and was proved to give independent information in risk stratification of patients. The aim of this study was to assess the usefulness of suPAR in the prediction of adverse card...
Autores principales: | Wlazeł, Rafał N., Migała, Marta, Zielińska, Marzenna, Pawlicki, Lucjan, Rośniak-Bąk, Kinga, Szadkowska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348361/ https://www.ncbi.nlm.nih.gov/pubmed/30697255 http://dx.doi.org/10.5114/aoms.2016.63596 |
Ejemplares similares
-
Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
por: Wlazeł, Rafał Nikodem, et al.
Publicado: (2018) -
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women
por: Wlazeł, Rafał Nikodem, et al.
Publicado: (2023) -
Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020) -
Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction
por: Sörensen, Nils A., et al.
Publicado: (2019) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)